Boothbay Fund Management, LLC Masimo Corp Transaction History

Boothbay Fund Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$115.24 - $144.91 $2.96 Million - $3.72 Million	25,648 Added 1471.49%	27,391 $3.45 Million
Q1 2024 May 15, 2024	BUY	$109.17 - $146.85 $190,283 - $255,959	1,743 New	1,743 $255,000
Q3 2022 Nov 14, 2022	BUY	$125.58 - $169.38 $132,110 - $178,187	1,052 Added 23.33%	5,561 $785,000
Q2 2022 Aug 15, 2022	SELL	$112.97 - $151.71 $376,077 - $505,042	-3,329 Reduced 42.47%	4,509 $589,000
Q1 2022 May 16, 2022	BUY	$135.71 - $284.87 $920,928 - $1.93 Million	6,786 Added 645.06%	7,838 $1.14 Million
Q4 2021 Feb 14, 2022	BUY	$266.41 - $303.29 $280,263 - $319,061	1,052 New	1,052 $308,000
Q3 2020 Nov 16, 2020	SELL	$209.49 - $246.81 $275,269 - $324,308	-1,314 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$178.49 - $250.39 $234,535 - $329,012	1,314 New	1,314 $300,000
Q4 2019 Feb 14, 2020	SELL	$140.81 - $159.49 $225,296 - $255,184	-1,600 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$145.61 - $159.87 $232,976 - $255,792	1,600 New	1,600 $238,000

403

43.1M

310K

268K

Ticker MASI
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 52,530,200
Market Cap $9.04B
Description
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximet...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.